Back

Impact of airline travel network on the global importation risk of monkeypox, 2022

Kinoshita, R.; Sassa, M.; Otake, S.; Yoshimatsu, F.; Shi, S.; Ueno, R.; Suzuki, M.; Yoneoka, D.

2022-09-18 epidemiology
10.1101/2022.09.17.22280060 medRxiv
Show abstract

BackgroundAs of 4 September 2020, a total of 53,996 monkeypox cases were confirmed globally. Currently, most monkeypox cases are concentrated in Europe and the Americas, while many countries outside these regions are also continuously observing imported cases. We aimed to estimate the potential global risk of monkeypox importation and consider hypothetical scenarios of travel restrictions by varying passenger volumes via airline travel network. MethodPassenger volume data for the airline network, and the time of first confirmed monkeypox case for a total of 1680 airports in 176 countries (and territories) were extracted from publicly available data sources. A survival analysis technique in which the hazard function was a function of effective distance was utilized to estimate the importation risk. Scenarios which selectively reduced the passenger volume from/to countries with detected monkeypox cases and increased/decreased the global passenger volume to the level of 2019 (high volume) or 2021 (low volume) regardless of monkeypox detection were considered for travel restrictions. ResultsThe arrival time ranged from 9 to 48 days since the first case was identified in the UK on 6 May 2022. The estimated risk of importation showed that regardless of the geographic region, most locations will have an intensified importation risk by 31 December 2022. Travel restrictions had a minor impact on the global airline importation risk against monkeypox. ConclusionsInstead of preventing the importation of monkeypox cases via airline networks, high risk countries should enhance local capacities for the identification of monkeypox and prepare to carry out contact tracing and isolation.

Matching journals

The top 1 journal accounts for 50% of the predicted probability mass.

1
Journal of Travel Medicine
18 papers in training set
Top 0.1%
52.4%
50% of probability mass above
2
PLOS ONE
4510 papers in training set
Top 21%
8.5%
3
International Journal of Environmental Research and Public Health
124 papers in training set
Top 2%
4.0%
4
Eurosurveillance
80 papers in training set
Top 0.3%
3.6%
5
Travel Medicine and Infectious Disease
15 papers in training set
Top 0.1%
2.1%
6
BMC Public Health
147 papers in training set
Top 3%
2.1%
7
Transboundary and Emerging Diseases
34 papers in training set
Top 0.3%
1.9%
8
Scientific Reports
3102 papers in training set
Top 55%
1.8%
9
Public Health
34 papers in training set
Top 0.7%
1.5%
10
International Journal of Infectious Diseases
126 papers in training set
Top 2%
1.1%
11
One Health
29 papers in training set
Top 1.0%
0.9%
12
PeerJ
261 papers in training set
Top 12%
0.9%
13
Clinical Infectious Diseases
231 papers in training set
Top 4%
0.8%
14
JMIR Public Health and Surveillance
45 papers in training set
Top 4%
0.7%
15
Annals of Internal Medicine
27 papers in training set
Top 1%
0.7%
16
The American Journal of Tropical Medicine and Hygiene
60 papers in training set
Top 5%
0.7%
17
Epidemiology and Infection
84 papers in training set
Top 4%
0.7%
18
BMJ Global Health
98 papers in training set
Top 3%
0.7%
19
The Lancet
16 papers in training set
Top 1.0%
0.5%
20
Infectious Disease Modelling
50 papers in training set
Top 1%
0.5%
21
Infectious Diseases
14 papers in training set
Top 0.4%
0.5%
22
Journal of Infection and Chemotherapy
16 papers in training set
Top 0.3%
0.5%
23
Journal of Infection
71 papers in training set
Top 4%
0.5%
24
The Innovation
12 papers in training set
Top 1%
0.5%
25
Emerging Infectious Diseases
103 papers in training set
Top 4%
0.5%